Second, it operationalizes the biologic link by showing loss of SDHB expression in the epithelial tumor on immunohistochemistry, which aligns with the World Health Organization concept of SDH-deficient NENs, and supports surveillance strategies that consider both paragangliomas and epithelial NETs in carriers of SDH variants [1,6,15]. Here, SDHB is linked to paraganglioma.